Oyster Point Pharma OYST
$ 11.17
0.0%
Quarterly report 2022-Q3
added 11-10-2022
Country |
USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Jeffrey Nau |
Employees in the company |
30 |
Shares |
26 M |
Market Cap[1] |
$ 300 M |
EBITDA (LTM) |
$ -136 M |
P/E (LTM) |
-1.95 |
P/S (LTM) |
9.69 |
EPS (LTM) |
-5.72 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.